Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data-Reference-Cited by-同舟云学术

Lipid-lowering efficacy of the PCSK9 inhibitor evolocumab (AMG 145) in patients with type 2 diabetes: a meta-analysis of individual patient data

Published:2016-05 Issue:5 Volume:4 Page:403-410
ISSN:2213-8587
Container-title:The Lancet Diabetes & Endocrinology
language:en
Short-container-title:The Lancet Diabetes & Endocrinology

Author:

Sattar Naveed,Preiss David,Robinson Jennifer G,Djedjos C Stephen,Elliott Mary,Somaratne Ransi,Wasserman Scott M,Raal Frederick J

Publisher

Elsevier BV

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference26 articles.

1. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies;Lancet,2010

2. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial;Colhoun;Lancet,2004

3. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: a meta-analysis;Lancet,2008

4. Ezetimibe added to statin therapy after acute coronary syndromes;Cannon;N Engl J Med,2015

5. Diabetes mellitus, fasting glucose, and risk of cause-specific death;Seshasai;N Engl J Med,2011

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of CETP, PCSK-9, and CYP7-alpha in cholesterol metabolism: Potential targets for natural products in managing hypercholesterolemia;Life Sciences;2024-08

2. The Predictive Utility of Circulating PCSK9 Levels on Diabetic Retinopathy Stage;Current Eye Research;2024-07-31

3. Efficacy and safety of proprotein convertase subtilisin kexin type (PCSK9) inhibitors in patients with acute coronary syndrome: A systematic review and meta-analysis;Medicine;2024-05-31

4. Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease—A Narrative Clinical Review;Pharmaceuticals;2024-04-29

5. Effectiveness and safety of injectable PCSK9 inhibitors in dyslipidaemias’ treatment and cardiovascular disease prevention: An overview of 86 systematic reviews and a network metaanalysis;Clínica e Investigación en Arteriosclerosis (English Edition);2024-03